Renaud Winzenrieth

R&D Department
Merignac, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 47 publications

Analyzing the effect of osteoporosis drug treatments on femoral strength using 3D-DXA finite elements modelling.

Analyzing the effect of osteoporosis drug treatments on femoral strength using 3D-DXA finite elements modelling.

Journal: Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry

Published: August 29, 2025

Abaloparatide effects on BMD in acetabular regions corresponding to DeLee and Charnley zones in women with postmenopausal osteoporosis.

Abaloparatide effects on BMD in acetabular regions corresponding to DeLee and Charnley zones in women with postmenopausal osteoporosis.

Journal: Bone reports

Published: March 18, 2025

Effects of romosozumab and teriparatide on hip bone using 3D-SHAPER in postmenopausal women with osteoporosis.

Effects of romosozumab and teriparatide on hip bone using 3D-SHAPER in postmenopausal women with osteoporosis.

Journal: JBMR plus

Published: January 22, 2025

Advanced 3D-DXA insights into bone density changes in hyperparathyroidism.

Advanced 3D-DXA insights into bone density changes in hyperparathyroidism.

Journal: Journal of diabetes and metabolic disorders

Published: May 24, 2024

Effects of Abaloparatide on Bone Mineral Density in Proximal Femoral Regions Corresponding to Arthroplasty Gruen Zones: A Study of Postmenopausal Women with Osteoporosis.

Effects of Abaloparatide on Bone Mineral Density in Proximal Femoral Regions Corresponding to Arthroplasty Gruen Zones: A Study of Postmenopausal Women with Osteoporosis.

Journal: The Journal of bone and joint surgery. American volume

Published: May 01, 2024

Trabecular bone score (TBS) in Cushing's disease: TBS gain after hypercortisolism normalization.

Trabecular bone score (TBS) in Cushing's disease: TBS gain after hypercortisolism normalization.

Journal: Bone

Published: January 19, 2024

Areal bone mineral density, trabecular bone score and 3D-DXA analysis of proximal femur in psoriatic disease.

Areal bone mineral density, trabecular bone score and 3D-DXA analysis of proximal femur in psoriatic disease.

Journal: Frontiers in medicine

Published: November 19, 2023

3D-modeling from hip DXA shows improved bone structure with romosozumab followed by denosumab or alendronate.

3D-modeling from hip DXA shows improved bone structure with romosozumab followed by denosumab or alendronate.

Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research

Published: March 30, 2023

Long-Term Effect of Denosumab on Bone Disease in Patients with CKD.

Long-Term Effect of Denosumab on Bone Disease in Patients with CKD.

Journal: Clinical journal of the American Society of Nephrology : CJASN

Published: February 02, 2023

Proximal Femur Responses to Sequential Therapy With Abaloparatide Followed by Alendronate in Postmenopausal Women With Osteoporosis by 3D Modeling of Hip Dual-Energy X-Ray Absorptiometry (DXA).

Proximal Femur Responses to Sequential Therapy With Abaloparatide Followed by Alendronate in Postmenopausal Women With Osteoporosis by 3D Modeling of Hip Dual-Energy X-Ray Absorptiometry (DXA).

Journal: JBMR plus

Published: December 09, 2021

Abaloparatide Effects on Cortical Volumetric BMD and Estimated Strength Indices of Hip Subregions by 3D-DXA in Women With Postmenopausal Osteoporosis.

Abaloparatide Effects on Cortical Volumetric BMD and Estimated Strength Indices of Hip Subregions by 3D-DXA in Women With Postmenopausal Osteoporosis.

Journal: Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry

Published: August 31, 2021

Response to "Concerns regarding the use of 3D-DXA".

Response to "Concerns regarding the use of 3D-DXA".

Journal: Bone

Published: March 26, 2021

Showing 1-12 of 47

Last Updated: 09/26/2026